In colon cancer, BRIP1 expression showed significant associations with several clinicopathological parameters, including gender, lymphatic invasion, CEA levels, pathological stage, M stage, N stage, MSI status, and anatomic tumor location. The gene discussed is CEACAM5; the disease is malignant colon neoplasm.